Antenatal magnesium sulfate and spontaneous intestinal perforation in infants less than 25 weeks gestation

J Perinatol. 2014 Nov;34(11):819-22. doi: 10.1038/jp.2014.106. Epub 2014 Jun 5.

Abstract

Objective: Evaluate spontaneous intestinal perforation (SIP)/death among extremely low birthweight (ELBW) infants before, during and after initiation of an antenatal magnesium for neuroprotection protocol (MgPro).

Study design: We tested associations between SIP/death and magnesium exposure, gestational age (GA) and interactions with GA and magnesium exposure in a cohort of inborn ELBW infants before, during and after MgPro.

Result: One hundred and fifty-five ELBW infants were included, 81 before, 23 during and 51 after MgPro. ELBW infants (78.3%) were exposed to Mg during MgPro compared with 50.6% and 60.8% before and after, respectively. Incidence of SIP on protocol was 30.4% vs 12.9% off protocol (P=0.03). GA was strongly associated with SIP (P<0.01). Antenatal Mg dose was also associated with SIP/death regardless of epoch (odds ratio 9.3 (1.04-104.6)), but increased SIP/death was limited to those <25 weeks gestation.

Conclusion: Higher Mg dose was associated with higher SIP and death risk among infants with the lowest birthweights. Validation of this observation in larger populations is warranted.

MeSH terms

  • Adult
  • Female
  • Gestational Age
  • Humans
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Infant, Premature, Diseases / chemically induced*
  • Intestinal Perforation / chemically induced*
  • Magnesium Sulfate / adverse effects*
  • Magnesium Sulfate / therapeutic use
  • Multivariate Analysis
  • Neuroprotective Agents / adverse effects*
  • Neuroprotective Agents / therapeutic use
  • Tocolytic Agents / adverse effects*
  • Tocolytic Agents / therapeutic use

Substances

  • Neuroprotective Agents
  • Tocolytic Agents
  • Magnesium Sulfate